APIXABAN GH (Lupin Australia Pty Limited)

[TRADE NAME] is indicated for:

• the prevention of venous thromboembolic events (VTE) in adult patients who have undergone elective total hip or total knee replacement surgery
• the prevention of stroke and systemic embolism in adult patients with non-valvular atrial fibrillation and at least one additional risk factor for stroke
• the treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE) in adult patients.
• the prevention of recurrent DVT and PE in adult patients.